Shanghai Allist Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 115.39

Shanghai Allist Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 4.0% on July 28, 2026. The stock reached an intraday low of CNY 115.39, reflecting a challenging trading session. Over the past week, the stock has seen a more significant decrease of 12.52%, contrasting with the China Shanghai Composite's decline of just 1.32%. Despite today's downturn, Shanghai Allist Pharmaceuticals has shown resilience over the longer term, with a one-month performance increase of 24.48% and a year-to-date gain of 11.71%. The company has maintained a strong market position, boasting a market capitalization of CNY 36,153 million and a price-to-earnings ratio of 15.00. Financially, Shanghai Allist has reported impressive metrics, including a net profit growth of 59.72% in the first half of the year and a return on equity of 30.78%. The company has consistently delivered positive results over the last ten quarters, indicating a solid operational foundation despite the current market fluctuations.